US pharmacy pricing
Jinteli Cost Without Insurance — US Pharmacy Price Guide
Lowest price found · US pharmacies
$29.46/fill
for Norethindrone-Eth Estradiol, across the pharmacies in our data
Discount card
$29.46
per fill
Lowest listed pharmacy price
Cost Plus Drugs
$3.58
per unit
Published price, no card needed
US pharmacy prices — 1 package (28 tablets), 1-5mg-mcg
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $29.46Lowest | $32.46 | $32.93 | |
| $32.73 | $35.73 | $32.93 | |
| $33.85 | $36.85 | $32.93 | |
| $33.85 | $36.85 | $32.93 | |
| $33.99 | $33.99 | $32.93 | |
| $43.75 | $46.75 | $32.93 | |
| $45.81 | $48.81 | $32.93 | |
| $45.81 | $48.81 | $32.93 | |
| $50.00 | $50.00 | $32.93 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Norethindrone-Eth Estradiol.
Frequently asked questions
What's the cash price for Norethindrone-Eth Estradiol (Jinteli) in the US?
At the US pharmacies in our data, the lowest listed discount-card price for Norethindrone-Eth Estradiol is around $29.46. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Can I buy Norethindrone-Eth Estradiol (Jinteli) at a Cost Plus Drugs price?
Yes — Cost Plus Drugs lists Norethindrone-Eth Estradiol at roughly $3.58 per unit, a published price with no membership card or coupon involved. See the three-price comparison above for how that stacks up against discount-card pharmacies.
Is a generic version of Norethindrone-Eth Estradiol available?
Generic and brand-name pricing for Norethindrone-Eth Estradiol is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
Is there a brand-name equivalent for Jinteli?
Jinteli is itself the authorized generic version of the brand-name medication Femhrt. It is manufactured by Teva Pharmaceuticals USA, Inc. Other brand-name medications used for similar menopausal symptoms include Premarin and Jevantique, though their active ingredients differ.
What is Jinteli, and what are its important safety considerations?
Jinteli is a combination hormone replacement therapy (HRT) prescribed to manage menopausal symptoms like hot flashes and vaginal dryness in women with an intact uterus. It contains ethinyl estradiol (an estrogen) and norethindrone (a progestin). The progestin component is crucial as it helps protect the uterine lining from the cancer risk associated with estrogen-alone therapy. Jinteli is contraindicated in many situations, including pregnancy, undiagnosed vaginal bleeding, certain cancers, a history of blood clots, stroke, heart attack, or liver disease. It is essential to disclose your full medical history, including conditions like lupus, asthma, migraines, or uterine fibroids, and all medications and supplements you take, to your doctor before starting treatment. Certain drugs, including some used for breast cancer or hepatitis C, can interact with Jinteli. Take it exactly as prescribed, typically at the same time each day, and follow up with your doctor regularly. Patients are advised to perform monthly breast self-exams, schedule routine mammograms, and avoid smoking and grapefruit products while on this medication.
What are the potential side effects of Jinteli?
Common side effects of Jinteli can include stomach pain, breast tenderness, bloating, weight changes, headaches, and vaginal spotting or breakthrough bleeding. As a hormone therapy, it carries serious risks, including an increased risk of certain cancers, blood clots, stroke, and heart attack. Seek immediate medical attention for symptoms like sudden severe headache, vision changes, chest pain, shortness of breath, leg swelling, slurred speech, weakness, or signs of a severe allergic reaction (hives, rash, swelling, difficulty breathing). This is not a complete list of side effects. Discuss the full risk profile with your healthcare provider and report any adverse reactions to the FDA.